Tranexamic Acid Tablet
Product Images NDC 72888-178

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tranexamic Acid (NDC 72888-178). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advagen Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tranexamic-acid-label-100 (Tranexamic Acid 100s Label)

Label for Tranexamic Acid Tablets, USP 650 mg oral tablets by Advagen Pharma Limited. The label indicates a 100 count package and includes usage and storage instructions, NDC 72888-178-01, and manufacturer details for Rubicon Research Pvt. Ltd., India. The label also notes prescription-only status and provides patient information web access.*

FDA Label Image

Tranexamic-acid-label-30 (Tranexamic Acid 30s Label)

Label for TRANEXAMIC ACID Tablets, USP 650 mg oral tablets by Advagen Pharma Limited. The label indicates a package size of 30 tablets with NDC 72888-178. It includes dosage instructions, storage information, distributor Advagen Pharma Ltd., and manufacturer Rubicon Research Pvt. Ltd., India. A barcode is also visible.*

FDA Label Image

Tranexamic-acid-label-500 (Tranexamic Acid 500s Label)

Label for Tranexamic Acid Tablets, USP 650 mg oral tablet by Advagen Pharma Limited. The label states a package size of 500 tablets, includes dosage instructions, storage conditions, and distributor and manufacturer information. It also features the product NDC 72888-178 and usage warnings.*

FDA Label Image

Figure-1-tranexamic-acid.jpg (Tranexamic Acid Figure 1)

A line graph depicting mean menstrual blood loss (mL) across different treatment periods, including first and second baselines followed by multiple treatment cycles. Four data sets are shown: Tranexamic Acid Tablets 3900 mg/day 3-cycle study, Placebo 3-cycle study, Tranexamic Acid Tablets 3900 mg/day 6-cycle study, and Placebo 6-cycle study. The graph compares blood loss trends over time between the Tranexamic Acid and placebo groups.*

FDA Label Image

Tranexamic-acid-structure (Tranexamic Acid Structure)

Chemical structure of tranexamic acid, depicting a cyclohexane ring with an amino group and a carboxylic acid substituent.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.